(Q41611759)

5 October 2017

1 reference

title

The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure (English)

1 reference

5 October 2017

Ferrari R

1

1 reference

PubMed ID

9330130

5 October 2017

De Giuli F

series ordinal

2

1 reference

5 October 2017

1 September 1997

1 reference

Journal of Cardiac Failure

5 October 2017

1 reference

5 October 2017

3

1 reference

5 October 2017

217-224

1 reference

5 October 2017

3

1 reference

Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation

5 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

The changing face of disorders of fatty acid oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Myocardial carnitine deficiency in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

[Heart failure in dilated cardiomyopathy and coronary heart disease. The contribution of biochemical parameters to assessing the prognosis]

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

The protective effect of carnitine in human diphtheric myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Anaplerotic effect of propionyl carnitine in rat heart mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Lack of correlation between the antiarrhythmic effect of L-propionylcarnitine on reoxygenation-induced arrhythmias and its electrophysiological properties

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Effect of propionyl-l-carnitine and enalapril on cardiac function of pressure-overloaded rats during increase in load.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Propionyl L-carnitine improvement of hypertrophied rat heart function is associated with an increase in cardiac efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Alterations in energy metabolism of hypertrophied rat cardiomyocytes: influence of propionyl-L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Protection of the reperfused heart by L-propionylcarnitine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Effects of some L-carnitine derivatives on heart membrane ATPases

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Factors determining symptoms in heart failure: comparison of fast and slow exercise tests

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Relation of pathophysiologic mechanisms to outcome in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Symptoms limiting exercise in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Factors contributing to the exercise limitation of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Effect of the sympathetic nervous system on limb circulation and metabolism during exercise in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

The emerging concept of vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Chronic changes in skeletal muscle histology and function in peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2897%2990018-X

7 January 2021

10.1016/S1071-9164(97)90018-X

Identifiers

DOI

1 reference

5 October 2017

1 reference

PubMed ID

9330130